Surufatinib (S) for patients (Pts) with advanced pancreatic neuroendocrine tumours (SANET-p): A randomized, double-blind, placebo (P)-controlled phase III trial (NCT02589821)

被引：1
|
作者：
Xu, J. [1 ]
Shen, L. [2 ]
Bai, C. [3 ]
Li, J. [2 ]
Zhou, Z. [4 ]
Yu, X. [5 ]
Li, Z. [6 ]
Li, E. [7 ]
Yuan, X. [8 ]
Chi, Y. [9 ,10 ]
Yin, Y. [11 ]
Lou, W. [12 ]
Xu, N. [13 ]
Bai, Y. [14 ]
Zhang, T. [15 ]
Xiu, D. [16 ]
Wang, X. [17 ]
Li, J. [2 ]
Fan, S.
Su, W. [18 ]
机构：
[1] Gen Hosp Peoples Liberat Army, Dept Gastrointestinal Oncol, Med Ctr 5, Beijing, Peoples R China
[2] Peking Univ Canc Hosp & Inst, Dept GI Oncol, Beijing, Peoples R China
[3] Peking Union Med Coll Hosp, Dept Oncol, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Gastr Surg,Canc Ctr, Guangzhou, Guangdong, Peoples R China
[5] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat & Hepatobiliary Surg, Shanghai, Peoples R China
[6] Sichuan Univ, West China Hosp, Dept Abdominal Oncol, Chengdu, Sichuan, Peoples R China
[7] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Shaanxi, Peoples R China
[8] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Hubei, Peoples R China
[9] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
[10] Peking Union Med Coll, Beijing, Peoples R China
[11] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China
[12] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
[13] Zhejiang Univ, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China
[14] Harbin Med Univ Canc Hosp, Dept Gastrointestinal Oncol, Harbin, Peoples R China
[15] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Canc Ctr, Wuhan, Hubei, Peoples R China
[16] Peking Univ, Hosp 3, Dept Gen Surg, Beijing, Peoples R China
[17] Shandong Univ, Qilu Hosp, Dept Med Oncol, Jinan, Peoples R China
[18] Hutchison MediPharma Ltd, Clin Dept & Regulatory Affairs, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1369
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1156O
引用
收藏
页码：S770 / S770
页数：1
相关论文
共 50 条
  • [41] Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial
    Umezawa, Yoshinori
    Nakagawa, Hidemi
    Tamaki, Kunihiko
    JOURNAL OF DERMATOLOGY, 2016, 43 (03): : 288 - 293
  • [42] A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    Kondo, Tomoyoshi
    Nomoto, Masahiro
    Origasa, Hideki
    Takahashi, Ryosuke
    Yamamoto, Mitsutoshi
    Yanagisawa, Nobuo
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (05) : 201 - 207
  • [43] Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors
    Rapp, Stephen R.
    Case, Doug
    Peiffer, Ann
    Naughton, Michelle Joy
    Stieber, Volker W.
    Bayer, Gerald K.
    Bilodeau, Paul A.
    Moore, Dennis Frederic
    Falchuk, Steven Charles
    Needles, Burton M.
    Piephoff, James
    Edenfield, William J.
    Giguere, Jeffrey K.
    Erickson, Nicholette
    Loghin, Monica Elena
    Shaw, Edward G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] BAYPAN study: A double-blind, phase III randomized trial of gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with advanced pancreatic cancer.
    Goncalves, A.
    Viret, F.
    Francois, E.
    Dahan, L.
    Perrier, H.
    Lamy, R.
    Re, D.
    Largillier, R.
    Gasmi, M.
    Tchiknavorian, X.
    Turrini, O.
    Moureau-Zabotto, L.
    Delpero, J.
    Viens, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Dasatinib combined with gemcitabine (Gem) in patients (pts) with locally advanced pancreatic adenocarcinoma (PaCa): Design of CA180-375, a placebo-controlled, randomized, double-blind phase II trial
    Evans, T. R. Jeffry
    Van Cutsem, Eric
    Moore, Malcolm J.
    Purvis, Joseph D.
    Strauss, Lewis C.
    Rock, Edwin P.
    Lee, Jennifer
    Lin, Chihche
    Rosemurgy, Alexander
    Arena, Francis P.
    Gara, Michelle
    Armstrong, Elizabeth
    O'Dwyer, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
    Li, Jin
    Qin, Shukui
    Xu, Jianming
    Xiong, Jianping
    Wu, Changping
    Bai, Yuxian
    Liu, Wei
    Tong, Jiandong
    Liu, Yunpeng
    Xu, Ruihua
    Wang, Zhehai
    Wang, Qiong
    Ouyang, Xuenong
    Yang, Yan
    Ba, Yi
    Liang, Jun
    Lin, Xiaoyan
    Luo, Deyun
    Zheng, Rongsheng
    Wang, Xin
    Sun, Guoping
    Wang, Liwei
    Zheng, Leizhen
    Guo, Hong
    Wu, Jingbo
    Xu, Nong
    Yang, Jianwei
    Zhang, Honggang
    Cheng, Ying
    Wang, Ningju
    Chen, Lei
    Fan, Zhining
    Sun, Piaoyang
    Yu, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1448 - +
  • [47] Gemcitabine/cisplatin plus bevacizumab or placebo in advanced malignant mesothelioma: A multi-center, double-blind, placebo-controlled, randomized phase III trial
    Kindler, H
    Lu, C
    Gandara, D
    Stevenson, J
    Krug, L
    Janne, P
    Gitlitz, B
    Karrison, T
    Stadler, W
    Vokes, E
    LUNG CANCER, 2005, 49 : S28 - S29
  • [48] EVEROLIMUS (EVE) FOR THE TREATMENT OF ADVANCED PANCREATIC NEUROENDOCRINE TUMORS (PNET): FINAL OVERALL SURVIVAL (OS) RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, MULTICENTER PHASE III TRIAL (RADIANT-3)
    Yao, J. C.
    Pavel, M.
    Lombard-Bohas, C.
    van Cutsem, E.
    Lam, D.
    Kunz, T.
    Brandt, U.
    Capdevila, J.
    De Vries, E. G. E.
    Hobday, T.
    Tomassetti, P.
    Pommier, R.
    ANNALS OF ONCOLOGY, 2014, 25
  • [49] Lanreotide autogel/depot in lung neuroendocrine tumours: The randomized, double-blind, placebo-controlled, international phase 3 SPINET Study
    Thanh, X-M. Truong
    Reidy-Lagunes, D.
    Kulke, M.
    Wolin, E.
    Singh, S.
    Ferone, D.
    Hoersch, D.
    Houchard, A.
    Caplin, M.
    Baudin, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S138 - S139
  • [50] Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial
    Lamy, M
    Eisele, B
    Keinecke, HO
    Delvos, U
    Thijs, LG
    9TH EUROPEAN CONGRESS ON INTENSIVE CARE MEDICINE, 1996, : 385 - 390
12345